In this work, we evaluated the molecular impact of the recently approved AR antagonist darolutamide in two different androgen‐dependent PCa cell lines and showed a potent and sustained reversal of genome‐wide AR binding and of the androgen‐induced transcriptome. Here, AR is linked to posterior cortical atrophy.